Melinta Therapeutics, LLC

Parsippany-Troy Hills, NJ Doing business as Melinta Therapeutics Part of Cormedix Inc.

UEI
H8K6F2A4KD49
CAGE
7XFT1
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
389 Interpace Pkwy #450, Parsippany-Troy Hills, NJ 07054, USA
Website
cormedix.com
Founded
2006
Employees
11-50
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Melinta Therapeutics, LLC's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Advance the development of two antibiotics for use in the pediatric population for the treatment of serious bacterial… Contract · 75A50123C00022 Office of the Assistant Secretary for Preparedness and Response $47,521,248

About Melinta Therapeutics, LLC

Written by GovTribe AI ·

Melinta Therapeutics, LLC, doing business as Melinta Therapeutics, is a for-profit limited liability company and manufacturer of goods registered to receive awards from the U.S. federal government. The company specializes in the development and production of antibiotics and pharmaceutical products, particularly those targeting serious bacterial infections and multidrug-resistant organisms. Melinta Therapeutics has been actively engaged in federal contracting since at least March 2018, when it first registered in SAM.gov. The company's expertise in antibiotic development positions it as a valuable partner for government agencies seeking to address public health concerns and biothreat emergencies.

The company's most significant recent federal contract award came from the Office of the Assistant Secretary for Preparedness and Response, a civilian agency. This $142,964,968.00 definitive cost-sharing contract, awarded on July 6, 2023, focuses on advancing the development of two antibiotics for use in the pediatric population to treat serious bacterial infections where multidrug-resistant organisms are common. Additionally, the contract supports the development of antibiotics for use in public health and biothreat emergencies. This substantial award, set to run until August 6, 2034, underscores Melinta Therapeutics' critical role in addressing urgent medical needs and strengthening national preparedness against potential biological threats.

Melinta Therapeutics holds several federal contract Indefinite Delivery Vehicles (IDVs), demonstrating its ongoing relationship with various government agencies. The company has a Federal Supply Schedule contract (36F79724D0178) awarded by the Department of Veterans Affairs, with a ceiling value of $9,658,300.00, for providing pharmaceutical, drug, and hematology-related products under category 65 IB. This multiple-award contract allows other federal agencies to procure these products through August 31, 2029. Additionally, Melinta has two Blanket Purchase Agreements (BPAs) with the National Acquisition Center, both for a product called REZZAYO. One BPA (36F79724D0178|36E79724A0033) has a ceiling value of $7,295.85 and runs until September 19, 2025, while the other (36F79718D0456|36E79724A0014) has a ceiling of $500,000.00 and is effective through August 31, 2024. The latter BPA is established under the GSA Pharmaceutical and Drugs (FSS-61-IB) schedule, indicating Melinta's ability to provide pharmaceutical products to various federal healthcare systems efficiently.

Contract vehicles

Melinta Therapeutics, LLC holds a place on 1 federal contract vehicle. Active vehicles first.

Quick answers

What is Melinta Therapeutics, LLC's UEI?

Melinta Therapeutics, LLC's Unique Entity ID (UEI) in SAM.gov is H8K6F2A4KD49.

What is Melinta Therapeutics, LLC's CAGE code?

Melinta Therapeutics, LLC's CAGE code is 7XFT1.

What is Melinta Therapeutics, LLC's primary NAICS code?

Melinta Therapeutics, LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Melinta Therapeutics, LLC located?

Melinta Therapeutics, LLC's physical address in SAM.gov is 389 Interpace Pkwy #450, Parsippany-Troy Hills, NJ 07054, USA.

Is Melinta Therapeutics, LLC registered in SAM.gov?

Yes. Melinta Therapeutics, LLC's SAM.gov registration is active through September 9, 2027.

Who is Melinta Therapeutics, LLC's parent company?

Melinta Therapeutics, LLC is part of Cormedix Inc.

Which contract vehicles does Melinta Therapeutics, LLC hold?

Melinta Therapeutics, LLC holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Melinta Therapeutics, LLC's most recent federal award?

Melinta Therapeutics, LLC's most recent federal contract award is Advance the development of two antibiotics for use in the pediatric population for the treatment of serious bacterial… (75A50123C00022), from Office of the Assistant Secretary for Preparedness and Response, on July 6, 2023.

On GovTribe

See Melinta Therapeutics, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login